(HealthDay)—A four-month rifapentine-based regimen containing moxifloxacin is noninferior to a standard six-month regimen for treatment of tuberculosis, according to a study published in the May 6 […]
German firm BioNTech said Thursday that patent protection for COVID-19 vaccines is not holding back production or supply of the jabs that it developed with Pfizer.
The average healthy woman begins menopause at 51, though some women will begin in their 40s or in their late 50s. It’s a natural biological process […]
(HealthDay)—High- and low-risk trajectories are identifiable for youth following their first opioid prescription, according to a study published online April 22 in JAMA Network Open.